Navigation Links
AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results
Date:8/11/2009

other 2,952 2,207 4,092 4,013 ------------------------------------------------------------------------- 8,379 10,457 14,490 20,205 ------------------------------------------------------------------------- Operating expenses Cost of sales 4,545 4,758 8,239 9,362 Research and development costs, net of tax credits and grants 12,076 17,345 23,513 31,034 Selling, general and administrative 3,102 6,606 6,656 11,010 Depreciation and amortization Property, plant and equipment 331 397 642 766 Intangible assets 563 876 1,120 1,716 ------------------------------------------------------------------------- 20,617 29,982 40,170 53,888 ------------------------------------------------------------------------- Loss from operations (12,238) (19,525) (25,680) (33,683) ------------------------------------------------------------------------- Other income (expenses) Interest income 118 311 274 588 Interest expense - (53) (2) (68) Foreign exchange (loss) gain (960) (502) (60) 1,753 Loss on disposal of long-lived assets held for sale - (810) - (35) ------------------------------------------------------------------------- (842) (1,054) 212 2,238 ------------------------------------------------------------------------- Net loss for the period (13,080) (20,579) (25,468) (31,445) ---------
'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Telbec/ - Mirego, leader in mobile strategies and solutions, is ... app extensions for the all new Apple Watch. Made in ... and MediaMiser, these extensions will reinvent the way users receive ... wrist use.  Available today in ... tactile smartwatch that makes for an excellent buddy for business, ...
(Date:4/23/2015)... Athena San Diego, an organization that ... in San Diego’s technology and life science sectors, will ... at their Gala on April 30, 2015 from 5-9pm ... http://athenasd.org/events/ , The Pinnacle Awards recognize individuals ... vision of fostering networking, risk taking and diversity of ...
(Date:4/23/2015)... , April 23, 2015  Neurocrine Biosciences, Inc. ... will report its first quarter 2015 results before the ... will then host a live conference call and webcast to ... Thursday morning, April 30, 2015 at 8:00 a.m. Eastern ... access the live conference call by dialing 866-952-1906 (US) ...
(Date:4/23/2015)... LONDON , April 23, 2015 ... Medical Equipment   Report Details   ... reach a value of $101.3 billion in 2015 and will ... Strong growth in the healthcare sectors around the world and ... the key growth factors in the global healthcare packaging ...
Breaking Biology Technology:Familiprix, OMSignal and MediaMiser apps available today for Apple Watch 2Athena Pinnacle Awards to Honor Executives, Corporations and Educators Working to Promote Women Leaders 2Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Healthcare Packaging Market Forecast 2015-2025 2Healthcare Packaging Market Forecast 2015-2025 3Healthcare Packaging Market Forecast 2015-2025 4Healthcare Packaging Market Forecast 2015-2025 5Healthcare Packaging Market Forecast 2015-2025 6Healthcare Packaging Market Forecast 2015-2025 7Healthcare Packaging Market Forecast 2015-2025 8Healthcare Packaging Market Forecast 2015-2025 9Healthcare Packaging Market Forecast 2015-2025 10
... , NEW YORK , ... NBS ) ("NeoStem" or the "Company"), an international,biopharmaceutical ... , today,announced that it has been awarded a ... Materiel Command, Telemedicine and Advanced Technology,Research Center (USAMRMC-TATRC) under ...
... July 12 Alaska Airlines (NYSE: ... International Airport, Seattle-Tacoma International Airport, Spokane International ... strategic initiative to promote aviation biofuel development in the Pacific ... the United States , the "Sustainable Aviation Fuels Northwest" project ...
... , , ... /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical ... formation of an international clinical advisory panel (the "Panel"). , ... This Panel of international experts with special expertise in ovarian ...
Cached Biology Technology:NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 2NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 3NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 4NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 5Transportation and Aviation Leaders Launch Sustainable Biofuels Initiative 2Transportation and Aviation Leaders Launch Sustainable Biofuels Initiative 3Quest PharmaTech Announces Formation of Clinical Advisory Panel 2Quest PharmaTech Announces Formation of Clinical Advisory Panel 3
(Date:4/10/2015)... , April 10, 2015 Research ... of the "Security Competitive Profiles - NEC" ... , NEC will continue to supply a ... the market, with a company focus on the development ... Winning opportunities in the Asia-Pacific ...
(Date:4/6/2015)... OXFORD, Conn. , Apr. 6, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/143028 for ... CLOSE-PROXIMITY COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces ... wireless payments. This patent surrounds the use of ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... revenues for Q1 2015 attributed to somewhat higher than ... company in the year-end report 2014 that revenues for ... MSEK that the company reported for Q4 2014. The ... continue to be negative. The complete interim report will ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2
... Patients with type 1 diabetes who used continuous ... experienced significant improvements in blood sugar control, according to ... by the Juvenile Diabetes Research Foundation. Results from the ... the Study of Diabetes (EASD) annual meeting in Rome, ...
... The American College of Clinical Pharmacology (ACCP) has ... PhD , director of Pediatric Clinical Pharmacology at ... Award. Dr. van den Anker, a neonatologist ... and prolific contributions to pediatric clinical pharmacology," according ...
... the choice all too frequently has come down to ... trigger indoor allergens. Today, The Clorox Company extends ... Anywhere® Anti-Allergen Fabric Spray, a new product to help ... Clorox® Anywhere® Anti-Allergen Fabric Spray denatures dust ...
Cached Biology News:JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control 2JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control 3The Clorox Company's new indoor allergen product reduces common indoor allergens up to 90 percent 2
... Services is a microarray ... industrial and academic researchers. We ... of Agilent, and we provide ... Agilent catalogue arrays. Gene ...
Immunogen GST fusion protein corresponding to full-length rat JNK3/ SAPK1b. Quality Assurance Routinely evaluated by immunoblot. Stability 2 years at -20°C from date of shipment GenBank A...
... post-translational modification that plays an important ... regulation, inflammation, cell-to-cell adhesion, and cell ... lectin based Glycoprotein Isolation Kits, Concanavalin ... (WGA), that allow isolation of glycoproteins ...
... series of laser scanners is the starting ... solution. ,Gene expression analysis, SNP (Single ... essential to the advancement of research in ... novel microarray formats and sizes. These arrays ...
Biology Products: